<http://schema.org/headline>
"BRIEF-Rigel Pharmaceuticals expects to file an investigational new drug application (IND) with FDA for its first IRAK inhibitor in 2017"^^<http://www.w3.org/2001/XMLSchema#string>
<http://in.reuters.com/article/idINFWN1CD091>